Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions
Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions have?
Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions has 371 citations in the OpenAlex counts ScholarIQ stores.
When was Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions published?
Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions has 1995 year in the ScholarIQ index.
What is the open-access status of Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions?
Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions has closed oa status in the ScholarIQ index.
What is the DOI of Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions?
The DOI for Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions is on the source record.
What is the PMID of Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions?
The PMID for Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions is on the source record.
What is the OpenAlex record for Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions?
The OpenAlex for Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions is on the source record.